Microport mainly engages in medical research and medical equipment production.
MicroPort, established in 1998, is a medical device manufacturer. The company's products cover ten major fields, such as implants, orthopedic medical devices, aortic and puncture vascular intervention products, electrophysiological medical devices and nerve implant products. Founded by Chang Yaohua, it went public on the Hong Kong Stock Exchange. The shareholders are Otsuka, Maxwell Maxcare Science, Shanghai ZJ Hi-Tech Investment, Starwick Investments. Microport's direct competitors include Lepu Medical and Weigao.
We-Linking Raised Over CNY 10 Mn in Angel Round
Intraoperative Neurophysiological Monitoring Equipment Developer NeuroFlag Closed An Angel Round
Surgerii Robotics: Single-Port Surgical Robots Poised to Transform Surgery
The worldwide surgical robotic market is expected to grow at a booming CAGR of 5.8% during 2022 to 2030, rising from USD 5.05 billion in 2022 to USD 21.41 billion in 2030. Of which, the single-port surgical robots that result in less pain, fewer scars, and quicker recovery, have tremendous up potential.
Mar 30, 2023 04:00 PM
ZD Medtech Raised Over CNY 100 Mn in Series B
Smart Powered Bionic Prosthetic Star BionicM Nets Over CNY 10 Mn
2022 China AI Health 30 Report
Medical Technology Company MacroLux Nets Nearly CNY 100 Mn in Series A
Fine Vision Completes Angel Financing Round Worth Nearly CNY 50 Mn
YingHe Neuro Raises Over CNY 100 Mn in Angel Round
Medical Equipment Company PowerSite Nets Over CNY 100 Mn in Series B
HastenPharma Secures USD 315 Mn in Financing to Focus on M&A Business and R&D
Anhui-based biopharmaceutical company HastenPharma(海森生物) raised USD 315 million in funding on April 20, with the financing round aimed at focusing on future mergers and acquisitions and product innovation, according to EqualOcean.
Apr 23, 2023 12:20 PM
Artificial Cardiac Company CoretechMed Raises Nearly CNY 200 Mn in Series C+
In the past five years, China's ventricular assist technology (i.e., "artificial heart") has developed rapidly, and three domestic implantable ventricular assist devices (LVADs) have been approved and marketed by the State Drug Administration, and another one is in the marketing declaration stage. The number of LVAD implantations has increased yearly, with a total of 363 LVAD implantations performed in 70 hospitals, a rapid increase.
Apr 17, 2023 05:12 PM
Equipment Company Keyto Nets Over CNY 100 Mn in Series C
IVD Company Bioantibody Nets Over CNY 100 Mn in Series A
Minimally invasive medicine proposes to spin off minimally invasive brain science and list it independently on the main board of the stock exchange
Global Leader in Radiosurgery Robots ZAP Sets Up China Headquarters in Suzhou
The China headquarters project of the ZAP-X photon surgery robot, led by ZAP, a global leader in the next-generation robotic surgical systems and a leading player in non-invasive brain surgery robots, has officially signed an agreement to settle in Suzhou.
Apr 13, 2023 04:06 PM
Clinical Microbiology Testing Company WillingMed Nets More than 100 Mn in Series B
WillingMed has independently developed and successfully reported and approved a series of automated testing instruments, software, testing reagents and other IVD products, and obtained intellectual property rights for more than 40 core technologies.
Apr 07, 2023 09:09 PM
Radio and television express: a variety of products and applications have been certified by financial Xinchuang ecological laboratory
Minimally invasive group investment holding Argus strengthens the multi-dimensional layout of precision medicine in the pan vascular field
China's Kwai Chung stock raising fund is HK $78 billion, and the scale of fund raising is expected to be quick.
Minimally invasive medical treatment: considering the separation of minimally invasive medical robot and independent listing